Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study

BACKGROUND: Large outbreaks of Lassa fever (LF) occur annually in Nigeria. The case fatality rate among hospitalised cases is ~ 20%. The antiviral drug ribavirin along with supportive care and rehydration are the recommended treatments but must be administered early (within 6 days of symptom onset)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Chandra, Nastassya L., Bolt, Hikaru, Dan-Nwafor, Chioma, Ipadeola, Oladipupo, Ilori, Elsie, Namara, Geoffrey, Olayinka, Adebola T., Ukponu, Winifred, Iniobong, Akanimo, Amedu, Michael, Akano, Adejoke, Akabike, Kachikwulu O., Okhuarobo, Uwaifiokun, Fagbemi, Stephen, Sampson, Emeka, Newitt, Sophie, Verlander, Neville Q., Bausch, Daniel G., le Polain de Waroux, Olivier, Ihekweazu, Chikwe
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7863257/
https://ncbi.nlm.nih.gov/pubmed/33541278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-05822-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados